| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Quit Smoking > Chantix: The New Quit Smoking Aid that Makes You Dislike the Effects of Nicotine |
|
E-Articles - Chantix: The New Quit Smoking Aid that Makes You Dislike the Effects of Nicotine
What is the most painful quit smoking challenge? Of course an honest answer to this would be controlling the uncontrollable According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ong>CRAVINGS. Would you quit smoking if you come to know that you can easily handle those cravings? I guess your answer ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in will be a ‘Yes’, because you know somewhere deep inside your heart that your smoking habit can only yield you bad health conditi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ns and take you closer to death. Every smoker, in some point of life, tries to get rid of his smoking habit, but we all know, it here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe is a task, easier said than done. Blame it on nicotine and its effects on brain. The kick of nicotine gives you a thrilling ple d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro sure making you a slave, and this is the reason behind your addiction to smoking. Just like any drug addict, you keep on increas ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ng the number of cigarettes to get the same level of pleasure. Your will power has to be very strong if you decide to bid this a easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ddiction good bye. But, fighting with the cravings and withdrawal is indeed not a matter of joke. After all, who likes coming cl nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ser to a diseased life and painful death with every fag of tobacco? What if you stop enjoying the nicotine kick after kissing y and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ur beloved Cigarette? Does that sound impossible? Do you think nicotine can never cheat you on drawing the momentary pleasure fr ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi m it? It will definitely cheat if you seek Chantix medication. Varenicline, the main ingredient of Chantix is a component that h ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a s the capacity to influence the brain receptor cells and give you similar pleasure like nicotine. Chantix competes with the amou dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod t of pleasure you get from nicotine, by getting attached to the a4?2 neuronal nicotinic acetylcholine receptors with high intens cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ty. As a result you do not feel like smoking and get over your withdrawal very soon. The Food and Drug Administration of Americ tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen a approved Chantix as a smoking cessation medicine on 11 May, 2006 for its notable potential to help smokers in quitting smoke. t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel itting the nicotine kick is hitting the bull’s eye! If you do not enjoy smoking why will you smoke then? Obviously the thrilling ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust kick was the sole reason for being in love with cigarette for so many years. If that feel-good factor is no more there, then I b y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products t you will cheat on your steady relationship with tobacco. Right isn’t it? Smokers! Tighten your belts and stand up! It is time . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de to put your shattered will-power together and try hard with new enthusiasm. Chantix is there for you to save you from your smoki elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip g cravings and withdrawal effects. Come on and join a smoke free world! We, the non-smoking people are waiting for you this side tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:I Was A Victim Of Intellectual Properties Theft Getting Hair Extensions - Step 6 of 6
|